We recently compiled a list of the 12 Best Long-Term Dividend Stocks to Invest in Right Now. In this article, we are going to ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

Medtronic has historically held roughly 50% share in its core heart devices. It's also the market leader in spinal products, insulin pumps, and neuromodulators for chronic pain. As smaller firms ...

Medtronic had to overcome a major supplier snafu in its latest quarter as it tried to keep pace with other large medical technology companies racing to commercialize new catheter technology that ...

Medtronic Percept neurostimulators send electrical signals through thin wires to specific brain regions affected by ...

Medtronic has reported revenue gains across ... The company also reported “high-teens growth” of its Micra leadless pacemaker. The Evolut FX+ was approved by the FDA this past March; the ...

Medtronic seems to be heading in the right direction, however, with eight straight quarters of year-on-year growth. The pace of innovation does seem to be picking up also, which opens up the ...

The global temporary pacing leads market is poised for significant growth, with sales estimated at USD 369.79 million in 2024 and projected to reach USD 519.56 million by 2034. This market expansion ...

Medtronic has reported new clinical data from the study of ... It reported a low rate of new 30-day permanent pacemaker ...